54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
18:34 UTC
|
CELH
Celsius
|
↓ Downgrade | Cristian Rios not yet tracked | Outperform→ Market Perform | $44.00→ $26.00-40.9% |
|
Aug 07
18:34 UTC
|
VRT
Vertiv
|
↑ Upgrade | Gordon L. Johnson not yet tracked | Hold→ Buy | $381.00 |
|
Aug 07
18:34 UTC
|
U
Unity Software
|
↑ Upgrade | Mike Hickey ★★☆☆☆ #2756 | Hold→ Buy | $50.00 |
|
Aug 07
17:34 UTC
|
ZVRA
Zevra Therapeutics
|
◎ Target | Eddie Hickman ★★★★☆ #900 | Buy | $24.00→ $23.00-4.2% |
|
Aug 07
17:34 UTC
|
XYZ
Block
|
◎ Target | Stephen Biggar ★★★★☆ #644 | Buy | $86.00→ $103.00+19.8% |
|
Aug 07
17:34 UTC
|
VCTR
Victory Capital
|
◎ Target | Michael Cho ★★★☆☆ #1541 | Neutral | $87.00→ $101.00+16.1% |
|
Aug 07
17:34 UTC
|
USFD
US Foods
|
◎ Target | John Heinbockel ★★★☆☆ #1621 | Buy | $115.00→ $120.00+4.3% |
|
Aug 07
17:34 UTC
|
TGTX
TG Therapeutics
|
◎ Target | Brian Cheng ★★☆☆☆ #2424 | Overweight | $65.00→ $72.00+10.8% |
|
Aug 07
17:34 UTC
|
TGT
Target
|
◎ Target | Christopher Horvers ★★★★★ #256 | Neutral | $129.00→ $157.00+21.7% |
|
Aug 07
17:34 UTC
|
TEAM
Atlassian
|
◎ Target | Howard Ma ★★★★★ #191 | Buy | $115.00→ $165.00+43.5% |
|
Aug 07
17:34 UTC
|
TAP
Molson Coors Beverage
|
◎ Target | Michael Lavery ★★★☆☆ #1053 | Neutral | $45.00→ $44.00-2.2% |
|
Aug 07
17:34 UTC
|
SVV
Savers Value Village
|
◎ Target | Peter Keith ★★★★☆ #558 | Neutral | $10.00→ $11.00+10.0% |
|
Aug 07
17:34 UTC
|
SVV
Savers Value Village
|
◎ Target | Matthew Boss ★★★★☆ #873 | Neutral | $11.00→ $14.00+27.3% |
|
Aug 07
17:34 UTC
|
SHC
Sotera Health
|
◎ Target | Casey Woodring ★★★★★ #9 | Neutral | $16.00→ $18.00+12.5% |
|
Aug 07
17:34 UTC
|
RYTM
Rhythm Pharmaceuticals
|
◎ Target | Priyanka Grover ★★☆☆☆ #2767 | Overweight | $145.00→ $146.00+0.7% |
|
Aug 07
17:34 UTC
|
RPRX
Royalty Pharma
|
◎ Target | Chris Schott ★★★★★ #265 | Overweight | $58.00→ $62.00+6.9% |
|
Aug 07
17:34 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Yatin Suneja ★☆☆☆☆ #2915 | Buy | $36.00→ $42.00+16.7% |
|
Aug 07
17:34 UTC
|
RMD
ResMed
|
◎ Target | Adam Maeder ★★★☆☆ #1398 | Neutral | $233.00→ $225.00-3.4% |
|
Aug 07
17:34 UTC
|
REPL
Replimune Group
|
◎ Target | Anupam Rama ★★☆☆☆ #2755 | Overweight | $17.00→ $20.00+17.6% |
|
Aug 07
17:34 UTC
|
QSR
Restaurant Brands International
|
◎ Target | Brian Mullan ★★☆☆☆ #2318 | Overweight | $85.00→ $81.00-4.7% |
|
Aug 07
17:34 UTC
|
QGEN
Qiagen
|
◎ Target | Casey Woodring ★★★★★ #9 | Overweight | $45.00→ $50.00+11.1% |
|
Aug 07
17:34 UTC
|
PZZA
Papa John's International
|
◎ Target | Brian Mullan ★★☆☆☆ #2318 | Neutral | $30.00→ $26.00-13.3% |
|
Aug 07
17:34 UTC
|
PAR
PAR Technology
|
◎ Target | Ella Smith ★★★★☆ #832 | Neutral | $17.00→ $18.00+5.9% |
|
Aug 07
17:34 UTC
|
OFRM
Once Upon A Farm
|
◎ Target | Thomas Palmer ★★★☆☆ #1710 | Overweight | $22.00→ $26.00+18.2% |
|
Aug 07
17:34 UTC
|
ODTX
Odyssey Therapeutics
|
◎ Target | Brian Cheng ★★☆☆☆ #2424 | Overweight | $26.00→ $29.00+11.5% |
|
Aug 07
17:34 UTC
|
NREF
NexPoint Real Estate Finance
|
◎ Target | Crispin Love ★★★☆☆ #1112 | Neutral | $16.00→ $17.50+9.4% |
|
Aug 07
17:34 UTC
|
NEWT
NewtekOne
|
◎ Target | Crispin Love ★★★☆☆ #1112 | Neutral | $14.00→ $15.00+7.1% |
|
Aug 07
17:34 UTC
|
NET
Cloudflare
|
◎ Target | John DiFucci ★★★★★ #107 | Sell | $140.00→ $160.00+14.3% |
|
Aug 07
17:34 UTC
|
MNST
Monster Beverage
|
◎ Target | Michael Lavery ★★★☆☆ #1053 | Overweight | $94.00→ $101.00+7.4% |
|
Aug 07
17:34 UTC
|
ICUI
ICU Medical
|
◎ Target | Jason Bednar ★★★★☆ #362 | Overweight | $163.00→ $195.00+19.6% |
|
Aug 07
17:34 UTC
|
GMAB
Genmab A/S
|
◎ Target | Michael Schmidt ★★☆☆☆ #2360 | Buy | $40.00→ $42.00+5.0% |
|
Aug 07
17:34 UTC
|
FWRG
First Watch Restaurant Group
|
◎ Target | Gregory Francfort ★★★☆☆ #1499 | Buy | $21.00→ $20.00-4.8% |
|
Aug 07
17:34 UTC
|
FROG
JFrog
|
◎ Target | Howard Ma ★★★★★ #191 | Buy | $105.00→ $115.00+9.5% |
|
Aug 07
17:34 UTC
|
CYRX
CryoPort
|
◎ Target | Subbu Nambi ★★★★★ #37 | Buy | $12.00→ $16.00+33.3% |
|
Aug 07
17:34 UTC
|
CMPX
Compass Therapeutics
|
◎ Target | Biren Amin ★☆☆☆☆ #3107 | Overweight | $4.00→ $6.00+50.0% |
|
Aug 07
17:34 UTC
|
CGON
CG Oncology
|
◎ Target | Kelsey Goodwin ★★☆☆☆ #2712 | Overweight | $82.00→ $85.00+3.7% |
|
Aug 07
17:34 UTC
|
CART
Maplebear
|
◎ Target | Taylor Manley not yet tracked | Neutral | $44.00→ $46.00+4.5% |
|
Aug 07
17:34 UTC
|
BP
BP
|
◎ Target | John Royall not yet tracked | Neutral | $42.00→ $43.00+2.4% |
|
Aug 07
17:34 UTC
|
BDX
Becton, Dickinson and Company
|
◎ Target | Jason Bednar ★★★★☆ #362 | Neutral | $161.00→ $175.00+8.7% |
|
Aug 07
17:34 UTC
|
AMPH
Amphastar Pharmaceuticals
|
◎ Target | David Amsellem ★★★★☆ #651 | Neutral | $21.00→ $20.00-4.8% |
|
Aug 07
17:34 UTC
|
AKAM
Akamai Technologies
|
◎ Target | John DiFucci ★★★★★ #107 | Buy | $181.00→ $190.00+5.0% |
|
Aug 07
17:34 UTC
|
ABX
Abacus Global Management
|
◎ Target | Crispin Love ★★★☆☆ #1112 | Neutral | $13.00→ $12.00-7.7% |
|
Aug 07
17:34 UTC
|
TCPC
Blackrock Tcp Capital
|
↑ Upgrade | firm only | Underperform→ Market Perform | |
|
Aug 07
17:34 UTC
|
FSLR
First Solar
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Aug 07
16:34 UTC
|
VIA
Via Transportation
|
◎ Target | Brian Schwartz ★★★☆☆ #2039 | Outperform | $25.00→ $30.00+20.0% |
|
Aug 07
16:34 UTC
|
UWMC
UWM
|
◎ Target | Kyle Joseph ★★☆☆☆ #2565 | Equal Weight | $3.00→ $2.00-33.3% |
|
Aug 07
16:34 UTC
|
TWLO
Twilio
|
◎ Target | Ryan MacWilliams ★★★★★ #314 | Overweight | $225.00→ $275.00+22.2% |
|
Aug 07
16:34 UTC
|
TRVI
Trevi Therapeutics
|
◎ Target | Leland Gershell ★☆☆☆☆ #3004 | Outperform | $24.00→ $25.00+4.2% |
|
Aug 07
16:34 UTC
|
TEAM
Atlassian
|
◎ Target | Ryan MacWilliams ★★★★★ #314 | Overweight | $140.00→ $180.00+28.6% |
|
Aug 07
16:34 UTC
|
RKT
Rocket Companies
|
◎ Target | Kyle Joseph ★★☆☆☆ #2565 | Overweight | $22.50→ $20.00-11.1% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.